Yuhan Corp. said Tuesday it has begun commercializing an artificial intelligence telemetry solution, MemoCue, with digital health care company Huino.
The system will be supplied to H Plus Yangji Hospital and applied to about 100 beds in key departments where cardiac monitoring is essential, the company said.
MemoCue analyzes hospitalized patients’ electrocardiogram data in real time to detect abnormal signs early and support clinicians’ decisions. It is designed to extend monitoring beyond intensive care units to general wards.
Yuhan said the system can use a hospital’s existing communications infrastructure without installing a separate network gateway, reducing the burden of adoption.
The solution includes a wearable ECG device, the Memo Patch M, designed with patient convenience and safety in mind. It uses a defibrillation protection circuit that delivers more than 99% of treatment energy to the patient and can resume measurement within five seconds after a shock, the company said.
The product received U.S. Food and Drug Administration 510(k) clearance last year and earned the top electrical safety rating under the international medical device safety standard IEC 60601-1, known as “Type CF Defib-proof.”
A Yuhan official said the company expects the system to help hospitalized patients recover by enabling accurate alerts and rapid response.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.